Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-09-26Clinical Trial Update: PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection [Phase 2]
A Phase 2 clinical trial evaluating PET/CT for diagnosing patients with liver cancer who are undergoing surgical resection has completed, wi…
-
CLINICAL_TRIALS trial_result · 2018-09-25Clinical Trial Update: A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma [Phase 3]
Phase 3 trial comparing lenvatinib to sorafenib as first-line therapy for unresectable hepatocellular carcinoma has completed; results were …
-
CLINICAL_TRIALS trial_result · 2018-09-11Clinical Trial Update: Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma (HCC) [Phase 4]
Phase 4 clinical trial update on palliative treatments for advanced hepatocellular carcinoma, completed.
-
CLINICAL_TRIALS trial_result · 2018-09-04Clinical Trial Update: Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase Ib/2 multicenter dose-escalation study of DCR-MYC in hepatocellular carcinoma was terminated, with results posted in September 2018.
-
CLINICAL_TRIALS trial_result · 2018-09-04Clinical Trial Update: Ph 2 Trial of ADI PEG 20 Plus Concurrent Transarterial Chemoembolization (TACE) Vs TACE Alone in Patients With Unresectable Hepatocellular Carcinoma [Phase 2]
Phase 2 trial evaluating ADI PEG 20 plus concurrent TACE versus TACE alone in unresectable hepatocellular carcinoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-08-27Clinical Trial Update: Advanced Image Guidance Utilized in Liver Surgery [NA]
A completed clinical trial evaluating advanced image guidance in liver surgery for hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2018-08-23Clinical Trial Update: A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating high-dose vitamin C for safety and potential efficacy in metastatic hepatocellular carcinoma (advance…
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: TACE Combined With RFA/MV Treatment in Hepatocellular Carcinoma Beyond Milan Criterial [Phase 3]
Phase 3 clinical trial evaluating transarterial chemoembolization (TACE) combined with radiofrequency/multivessel (RFA/MV) treatment for hep…
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: Taiwan ACE Beads for Hepatoma Embolization Therapy [NA]
Clinical trial update for Taiwan ACE Beads used in hepatoma embolization therapy; study completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-02Clinical Trial Update: Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria [Phase 3]
Phase 3 trial update on neoadjuvant hepatic arterial infusion chemotherapy (HAIC) for resectable hepatocellular carcinoma beyond Milan crite…
-
CLINICAL_TRIALS trial_result · 2018-08-02Clinical Trial Update: Hepatectomy Versus Chemoembolization for Resectable Hepatocellular Carcinoma Beyond Milan Criteria [Phase 4]
Phase 4 trial comparing hepatectomy to chemoembolization for resectable hepatocellular carcinoma beyond Milan criteria; status of the study …
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial is investigating cannabidiol for efficacy in multiple myeloma, glioblastoma, and various gastrointestinal cancers…
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC [Phase 1, Phase 2]
A clinical trial update for SHR-1210 in combination with SHR6390 in patients with advanced colorectal cancer, non-small cell lung cancer, an…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Chemoembolization Using Doxorubicin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery [NA]
This clinical trial update notes the completion of a trial evaluating chemoembolization with doxorubicin for unresectable liver cancer, with…
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: 3-Tesla MRI Response to TACE in HCC (Liver Cancer) [NA]
Clinical trial update noting 3-Tesla MRI responses to transarterial chemoembolization in hepatocellular carcinoma, with the study terminated…
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: Sorafenib Versus Best Supportive Care in Egyptian Hepatocellular Carcinoma Patients. [Phase 3]
A Phase 3 trial comparing sorafenib with best supportive care in Egyptian patients with hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-21Clinical Trial Update: DEB-TACE for Hepatocellular Carcinoma [NA]
A clinical trial investigating drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-06-21Clinical Trial Update: Pilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular Carcinoma [NA]
A pilot clinical trial evaluating UNI-DEB for unresectable hepatocellular carcinoma conducted by Jeil Pharmaceutical Co., Ltd. has completed…
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating transarterial chemoembolisation (TACE) plus axitinib in hepatoce…
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: A Study of IMC-A12 in Combination With Sorafenib in Participants With Advanced Cancer of the Liver [Phase 2]
Phase 2 study of IMC-A12 plus sorafenib in hepatocellular carcinoma completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: An Open Study Assessing the Safety and Tolerability of U3-1784 [Phase 1]
Phase 1 open-label study to assess safety and tolerability of the investigational drug U3-1784 in patients with advanced solid tumors and he…
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases [NA]
This clinical trial update evaluated safety, efficacy, and dosing of stereotactic radiosurgery for liver metastases arising from hepatocellu…
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: Influence of Probiotics Administration Before Liver Resection in Liver Disease [NA]
A completed clinical trial evaluated the influence of administering probiotics before liver resection in patients with liver disease. The sn…
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer [Phase 1]
A Phase 1 clinical trial evaluating autologous immune killer cells in patients with late-stage non-small cell lung cancer and hepatocellular…
-
CLINICAL_TRIALS trial_result · 2018-05-08Clinical Trial Update: Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis [Phase 4]
An update on a Phase 4 trial comparing sorafenib monotherapy to TACE-sorafenib sequential therapy in hepatocellular carcinoma with metastasi…